Stoboclo™
Active ingredients: Denosumab
Pack: Stoboclo 60 mg/mL injection, 1 mL syringe
Consumer medicine information
Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
The treatment of osteoporosis in postmenopausal women. STOBOCLO significantly reduces the risk of vertebral, non-vertebral and hip fractures. Treatment to increase bone mass in men with osteopaenia receiving androgen deprivation therapy for non-metastatic prostate cancer (see section 5.1 Pharmacodynamic properties, Clinical trials). Treatment to increase bone mass in men with osteoporosis at increased risk of fracture. Treatment to increase bone mass in women and men at increased risk of fracture due to long-term systemic glucocorticoid therapy.
Source: ARTG
Storage conditions
- Shelf lifetime is 54 Months
- Store at 2 to 8 degrees Celsius
- Protect from Light; Do not Freeze; Refrigerate; Store in Original Container; Do not Shake
Source: ARTG
How to use this medicine
Non-composite pack
This medicine contains one component only.
Component
- Injection, solution
- Subcutaneous
- Clear, colourless to slightly yellow solution.
Source: ARTG
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
- 1 pre-filled syringe
Source: ARTG
Is this medicine subsidised?
This medicine was verified as available on the Pharmaceutical Benefits Scheme (PBS) on 1 November 2026, under PBS item code 5457F (Opens in new tab). Ask your pharmacist or doctor about your eligibility
Source: PBS
Reporting side effects
If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).
You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)
Source: ARTG
Data sources
- Australian Health Thesaurus (AHT) (Opens in new tab) – Last updated on 4 November 2026
- Australian Medicines Terminology (AMT) (Opens in new tab) – Last updated on 4 November 2026
- Australian Register of Therapeutic Goods (ARTG) (Opens in new tab) – Last updated on 4 November 2026
- Pharmaceutical Benefits Scheme (PBS) (Opens in new tab) – Last updated on 4 November 2026
- Medicines Information Pty Ltd (Opens in new tab) – Last updated on 4 November 2026
Disclaimer
Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).
Symptom Checker
Worried about your health?
Select a symptom, answer some questions, get advice
